| Cell line name |
ClearCa-12 |
|---|
| Synonyms |
clearCa-12 |
|---|
| Accession |
CVCL_X551 |
|---|
| Resource Identification Initiative |
To cite this cell line use: ClearCa-12 (RRID:CVCL_X551) |
|---|
| Comments |
Doubling time: 104 hours (PubMed=9146668). |
|---|
| Sequence variations |
|
|---|
| Disease |
Clear cell renal cell carcinoma (NCIt: C4033)
Clear cell renal carcinoma (ORDO: Orphanet_319276) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
60Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=9146668; DOI=10.1016/S0022-5347(01)64778-5
Ramp U., Jaquet K., Reinecke P., Schardt C., Friebe-Hoffmann U., Nitsch T., Marx N., Gabbert H.E., Gerharz C.-D.
Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
J. Urol. 157:2345-2350(1997) CLPUB00411
Petek O.
Analysis of expression and mutation of the antimetastatic gene NM23 in human renal carcinoma cell lines and epithelioid sarcomas.
Thesis MD (2002); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany CLPUB00407
Krieg A.
Characterization and functional analysis of the TRAIL system and the inhibitor of apoptosis protein (IAP) family in human neoplasia.
Thesis MD (2005); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany PubMed=15863265; DOI=10.1016/j.canlet.2004.09.045
Reinecke P., Kalinski T., Mahotka C., Schmitz M., Dejosez M., Gabbert H.E., Gerharz C.-D.
Paclitaxel/taxol sensitivity in human renal cell carcinoma is not determined by the p53 status.
Cancer Lett. 222:165-171(2005) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54813593
|
|---|
| Polymorphism and mutation databases |
IARC_TP53; 23214
|
|---|
| Entry history |
|---|
| Entry creation | 05-Sep-2014 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 10 |
|---|
